Skip to main content
Psych Congress 2023 Main banner

Full Schedule

Full Schedule

  • Sunday, September 10, 2023
  • 8:30 AM – 9:00 AM CT
    Coffee and Continental Breakfast
  • 9:00 AM – 10:15 AM CT
    Clinicians Advocating for Change: Importance of Public Policy Engagement for Enhancing Patient Care

    Speaker: Andrew Smith, LSW, MPH – Depression and Bipolar Support Alliance

    Speaker: Jill Harkavy-Friedman, PhD – American Foundation for Suicide Prevention

    Advocacy can bring about significant positive change for mental health care providers and their patients. It can improve access to care, increase funding for mental health services, and promote better mental health policies. By sharing stories of successful advocacy campaigns, we hope to inspire attendees to become more involved in advocacy efforts and make a difference in their communities. We will also discuss practical ways to get people more involved in advocacy, such as forming coalitions, using social media, and reaching out to local lawmakers. By the end of this session, attendees will be equipped with the knowledge and tools they need to become effective advocates for mental health care in their communities.

    Developed in partnership with Depression and Bipolar Support Alliance

    Click to Read More

    Patient Advocacy

  • 9:00 AM – 10:15 AM CT
    Exploring the Science of Cannabis: Navigating Benefits, Risks, and Interactions

    Speaker: Andrew D. Penn, MS, PMHNP – University of California, San Francisco, School of Nursing

    The use of medical marijuana has gained significant attention and controversy in recent years. In this session, we will explore the current state of the science of cannabis and its use as medical marijuana, including its potential benefits, risks, and interactions with medications. This session aims to provide attendees with a comprehensive understanding of the current landscape of medical marijuana and equip them with the knowledge they need to make informed decisions about its use.

    Integrative Care

  • 9:00 AM – 10:15 AM CT
    Managing Adverse Effects of Atypical Antipsychotics

    Speaker: Christoph U. Correll, MD – (1) The Zucker Hillside Hospital; (2) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; (3) The Feinstein Institutes for Medical Research; (4) Charité - Universitätsmedizin Berlin

    Atypical antipsychotics are commonly prescribed for the treatment of various psychiatric disorders, but their use can be associated with a range of adverse effects. The session will cover the most common side effects associated with atypical antipsychotics, including metabolic disturbances, movement disorders, and cardiovascular complications. Strategies for managing these side effects, such as prescribing adjunctive medications, lifestyle modifications, and patient education will be discussed. Participants will leave this session with a deeper understanding of the side effects of atypical antipsychotics and the skills to effectively manage them in their clinical practice.

    Psychotic Disorders

    Depressive Disorders

  • 10:30 AM – 11:45 AM CT
    Understanding the Role of TAAR1 Agonism in Schizophrenia: Framing the Story around the Whole Patient

    Speaker: Amber Hoberg, PMHNP-BC – Morning Star Family Medicine PLLC

    Speaker: Christoph U. Correll, MD – (1) The Zucker Hillside Hospital; (2) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; (3) The Feinstein Institutes for Medical Research; (4) Charité - Universitätsmedizin Berlin

    Brunch will be served. Seating will be limited.

    The session will begin with a unique poster review before expert faculty dive into the lecture. Grab a headset and take a tour of 3 different posters, each highlighting current data on TAAR1 agonists. The lecture portion of this session will begin by discussing the limitations and barriers associated with the use of antipsychotics for schizophrenia whose MOA centers on dopamine D2 binding. Expert faculty will evaluate the mechanism of action and safety/efficacy data associated with TAAR1 agonism in the management of schizophrenia, followed by a discussion of potential clinical implications for TAAR1 agonists and how to identify and educate patients who might benefit from these novel therapies.

    Click to Read More

    Master Class

  • 12:00 PM – 1:15 PM CT
    Bipolar Disorder and Co-occurring Substance Use and Misuse

    Speaker: Joseph F. Goldberg, MD – Icahn School of Medicine at Mount Sinai

    Individuals with bipolar disorder are at a higher risk of developing substance use disorders, which can significantly complicate the management of their bipolar symptoms. The session will provide an overview of the prevalence and impact of co-occurring substance use and bipolar disorder, explore the complex interplay between substance use and bipolar disorder, including how substance use can trigger or exacerbate bipolar symptoms, and examine how bipolar disorder can increase the risk of substance use.

    Click to Read More

    Bipolar Disorders

    Addiction & Substance Use Disorders

  • 12:00 PM – 1:15 PM CT
    CANCELED Navigating the Double Challenge of Geriatric Depression and Dementia

    Speaker: Gary Small, MD – Hackensack Meridian School of Medicine

    As the population continues to age, the prevalence of both depression and dementia in older adults is expected to increase. For psychiatric medical professionals, the management of these dual challenges can be complex and require a nuanced approach. This session will explore the intersection of geriatric depression and dementia and provide practical guidance in the assessment, diagnosis, and treatment of these conditions.

    Click to Read More

    Geriatric Psychiatry

    Depressive Disorders

    Dementia & Cognitive Disorders

  • 12:00 PM – 1:15 PM CT
    Expert Panel: Optimizing Use of Long-Acting Injectable Medications in People with Schizophrenia in Community Settings

    Speaker: Leslie L. Citrome, MD, MPH – Department of Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, NY

    Speaker: Amber Hoberg, PMHNP-BC – Morning Star Family Medicine PLLC

    Speaker: Max E. Guttman, LCSW – Recovery Now, LLC

    Long-acting injectable (LAI) medications have become an essential tool in the management of schizophrenia, particularly in patients with poor medication adherence and/or a history of frequent hospitalizations. This session will explore the benefits of LAIs, including improved symptom control, reduced hospitalization rates, and increased quality of life, through a discussion from panelists, including that from the perspective of an ACT team. The ACT team, or Assertive Community Treatment team, is a specialized type of multidisciplinary mental health care team that provides intensive and comprehensive treatment to individuals with severe and persistent mental illnesses who have complex and often multiple needs. The team uses a patient-centered approach, and works closely with patients and their families to develop individualized treatment plans that are tailored to meet each patient's unique needs and goals.

    Click to Read More

    Psychotic Disorders

  • 1:30 PM – 2:45 PM CT
    From Beethoven to Beyonce': Music's Neurobiology and Clinical Applications Psychiatry

    Speaker: Rakesh Jain, MD – Texas Tech - Permian Basin

    Music moves us, music uplifts us. Music accompanies us from birth to death. But, does music have a role in mental health and mental wellness? This presentation will examine the deep neurobiology of music and its clinical application in various disorders in psychiatry - ranging from autism to dementia, spanning from the young to the old, and as therapy and as a prophylactic to preventing depression and anxiety disorders. This presentation will extensively use music clips to demonstrate various applications of music in our clinical practices.

    Wellness

  • 2:45 PM – 3:00 PM CT
    Psych Congress 2023: Final Thoughts and Panel Discussion
    Join Psych Congress 2023 Co-Chairs and the entire Steering Committee for an interactive “wrap-up” and panel discussion focusing on conference highlights from the previous 4 days of educational sessions.